Drug intelligence / Profile preview

Xianyu capsule

Development stage
Unknown
Lead developer
The First Affiliated Hospital of Zhengzhou University
Administration
Oral
01

Overview

Xianyu capsule is a traditional Chinese medicine (TCM) formulation used as an antiepileptic therapeutic agent. It is formulated by modifying and combining two classical TCM prescriptions: Qianzheng San (Symmetry-Restoring Powder) and Tianma Gouteng Yin (Gastrodia-Uncaria Decoction). The product contains 16 herbal ingredients, including Hedysarum Multijugum Maxim., Codonopsis Radix, Radix Salviae, Radix Bupleuri, Ziziphi Spinosae Semen, Polygala tenuifolia Willd., Rhizom Gastrodiae, Uncariae Ramulus Cumuncis, Curcumae Radix, Arisaema Cum Bile, Angelicae Sinensis Radix, Acoritataninowii Rhizoma, Bombyx Batryticatus, Massa Medicata Fermentata, licorice, Typhonii Rhizoma, and Glycyrrhiza uralensis Fisch. Clinical evidence suggests it modulates neuroinflammation and glycerophospholipid metabolism—potentially by regulating AKT1, insulin (INS), and interleukin-6 (IL-6)—and that its mechanism may involve effects on gut microbiota, lipid metabolism, and neuroinflammatory pathways. It is approved and used in China for the treatment of epilepsy, where it has demonstrated sedative, anticonvulsant, wind-extinguishing, and spasmolytic effects, with more than twenty years of clinical use[1][2].

Brand names
Xianyu capsule
Other names
XYC
02

Targets

IL-6 (Interleukin 6)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on Xianyu capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xianyu capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call